BioMarin promotes Jeff Ajer to the post of Senior VP, Chief Commercial Officer

By Admin
BioMarin Pharmaceuticals Inc Thursday said it has announced that Jeff Ajer, the present Vice President, Commercial Operations; the Americas will be pro...

BioMarin Pharmaceuticals Inc Thursday said it has announced that Jeff Ajer, the present Vice President, Commercial Operations; the Americas will be promoted to the post of Senior Vice President, Chief Commercial Officer.  

Mr. Ajer has over more than 20 years of experience in building industry-leading  commercial companies within rare disease and specialty medicine.

Mr. Ajer will also be leading the company’s global marketing and sales companies and report directly to CEO of BioMarin Jean –Jacques Bienaimé.  His recent role involved P&L responsibility for commercial operations throughout the Americas, including the markets critical for company growth such as Brazil and the U.S. He also led the product marketing, reimbursement and sales operations for BioMarin. 

He has also played a leadership role in establishing  BioMarin’s successful  commercial infrastructure and global footprint, shaped the launches and growth strategies for Naglazyme and Kuvan.

Jeff also led the commercial planning for late-stage pipeline programs including GALNS.  He joined the company in 2005 as a Vice President of Sales and Marketing Operations.  Before being part of BioMarin, Mr. Ajer  also served as Vice President, Global Transplant Operations at Genzyme Corporation.   

The Executive Vice President, Chief Business Officer, Stephen Aselage will be leaving the company to pursue opportunities from October 15.  He will also get a severance package based on the terms of his employment agreement.

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company’s product portfolio comprises four approved drugs and multiple clinical and pre-clinical product candidates.

Share
Share

Featured Articles

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

CGI is driving efficiency in healthcare. Hear from Helena Jochberger, at Manufacturing Digital LIVE, a free virtual event on Wednesday 6th December 2023

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML

Healthtech platform CoverSelf extends seed round to US$8.2m

Technology & AI